RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer (Triple Negative Breast Cancer (TNBC))
Interventions: BIOLOGICAL: IVAC_W_bre1_uID|BIOLOGICAL: IVAC_W_bre1_uID/IVAC_M_uID
Sponsor: BioNTech SE
Collaborators: Seventh Framework Programme